Literature DB >> 28881884

Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.

S M Lagarde1,2, A W Phillips1, M Navidi1, B Disep1, S M Griffin1.   

Abstract

Dissection of lymph nodes (LN) immediately after esophagectomy is utilized by some surgeons to aid determination of LN stations involved in esophageal cancer. Some suggest that this increases LN yield and gives information regarding the pattern of lymphatic spread, others feel that this may compromise a circumferential resection margin (CRM) assessment. The aim of this study is to evaluate the effect of ex vivo dissection on the assessment of the CRM and the pattern of lymph node dissemination in patients with adenocarcinoma of the esophagus and gastroesophageal junction (GEJ) undergoing radical surgery after neoadjuvant chemotherapy and their prognostic impact. Data from consecutive patients with potentially curable adenocarcinoma of the distal esophagus and GEJ who received neoadjuvant treatment followed by surgery were analyzed. Clinical and pathological findings were reviewed and LN burden and location correlated with clinical outcome. Pathology specimens were dissected into individual LN groups 'ex-vivo' by the surgeon. A total of 301 patients were included: 295 had a radical proximal and distal resection margin however in 62(20.6%) CRM could not be assessed. A median of 33(10-77) nodes were recovered. A 117(38.9%) patients were ypN0 while 184(61.1%) were LN positive (ypN1-N3). LN stations close to the tumor were most frequently involved. Twenty-seven (14.7%) patients had only thoracic stations involved, 48(26.1%) only abdominal stations and 109 (59.2%) had both. Median survival for yN0 patients was 171 months compared to 24 months for those LN positive (P< 0.001). Multivariate analyses identified ypT-category, ypN-category, male gender, and nonradical resection (proximal or distal) margin as significant prognostic factors. Surgical dissection of nodes after esophagectomy enables accurate LN assessment, but may compromise CRM assessment in up to 20% of cases. It also provides valuable information regarding the pattern of nodal spread.
© The Authors 2017. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  esophageal adenocarcinoma; esophagectomy; ex-vivo dissection of nodes; lymph node yield; lymphadenectomy

Mesh:

Year:  2017        PMID: 28881884     DOI: 10.1093/dote/dox086

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity.

Authors:  C Mann; F Berlth; E Hadzijusufovic; E Tagkalos; E Uzun; C Codony; H Lang; P P Grimminger
Journal:  BMC Cancer       Date:  2022-05-24       Impact factor: 4.638

2.  Evolution of Esophagectomy for Cancer Over 30 Years: Changes in Presentation, Management and Outcomes.

Authors:  S Michael Griffin; Rhys Jones; Sivesh Kathir Kamarajah; Maziar Navidi; Shajahan Wahed; Arul Immanuel; Nick Hayes; Alexander W Phillips
Journal:  Ann Surg Oncol       Date:  2020-10-18       Impact factor: 5.344

3.  Solitary Celiac Lymph Node Metastasis Has a Better Long-Term Survival Compared With Solitary Mediastinal Lymph Node Metastasis in Esophagectomy of Esophageal Squamous Cell Cancer: A Propensity Score Matching Analysis.

Authors:  Kun-Kun Li; Tao Bao; Ying-Jian Wang; Xiao-Long Zhao; Jiang Long; Xian-Feng Xie; Wei Guo
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

Review 4.  Evidence-based approach to the treatment of esophagogastric junction tumors.

Authors:  Francisco Schlottmann; María A Casas; Daniela Molena
Journal:  World J Clin Oncol       Date:  2022-03-24

Review 5.  Mediastinal lymphadenectomy for esophageal cancer: Differences between two countries, Japan and the Netherlands.

Authors:  Miguel A Cuesta; Donald L van der Peet; Suzanne S Gisbertz; Jennifer Straatman
Journal:  Ann Gastroenterol Surg       Date:  2018-05-01

6.  Anastomotic Leak Does Not Impact on Long-Term Outcomes in Esophageal Cancer Patients.

Authors:  S K Kamarajah; M Navidi; S Wahed; A Immanuel; N Hayes; S M Griffin; A W Phillips
Journal:  Ann Surg Oncol       Date:  2020-01-23       Impact factor: 5.344

7.  Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction.

Authors:  S K Kamarajah; M Navidi; S Wahed; A Immanuel; N Hayes; S M Griffin; A W Phillips
Journal:  Ann Surg Oncol       Date:  2020-03-21       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.